Status:
UNKNOWN
The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Rhinoplasty
Nasal Obstruction
Eligibility:
All Genders
14-80 years
Phase:
NA
Brief Summary
Nasal obstruction is one of the majors concerns in reduction rhinoseptoplasty, because it affects quality of life and surgical outcomes. Is the association of middle third grafts with reduction rhinos...
Detailed Description
Reduction rhinoplasty and rhinoseptoplasty are among the most accomplished aesthetic procedures in Plastic Surgery and Otorhinolaryngology. Nasal obstruction is one of the majors concerns in this proc...
Eligibility Criteria
Inclusion
- Patients eligible for reduction rhinoseptoplasty who agreed to participate in the study and who did not meet the exclusion criteria
Exclusion
- Absence of nasal obstruction;
- Previous nasosinusal surgery;
- Symmetrical or asymmetric insufficiency of the middle third that would justify the placement of middle third grafts for the treatment of these problems;
- Presence of nasal valve insufficiency as the only cause of nasal obstruction;
- Cranio-facial anomalies;
- Presence of nasosinusal tumors;
- Active acute rhinosinusitis;
- Patients undergoing treatment of other entities concomitant to rhinoseptoplasty such as: sinus inflammatory surgery, adenoid hypertrophy removal, septal perforation correction, otoplasty or blepharoplasty.
Key Trial Info
Start Date :
October 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04499469
Start Date
October 3 2018
End Date
June 1 2021
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raphaella Migliavacca
Porto Alegre, Rio Grande do Sul, Brazil, 90480030